Brush up your pathology policies involving genomic testing to keep pace with the latest testing options covered under Medicare, which recently revised a national coverage determination (NCD) for next generation sequencing (NGS).
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.
Quick, Current, Complete - www.findacode.com